Antidepressant stops growth of plaques in mouse style of Alzheimer’s disease A commonly prescribed antidepressant can reduce creation of the main ingredient in Alzheimer's human brain plaques, according to new analysis at Washington University School of Medicine in St widely demanded . Louis and the University of Pennsylvania. The findings, in people and mice, are published May 14 in Science Translational Medicine. They support preliminary mouse studies that evaluated a number of antidepressants. Human brain plaques are tied closely to memory complications and additional cognitive impairments caused by Alzheimer's disease.
James Crowe Junior, a professor of pediatrics and director of the Vanderbilt Plan in Vaccine Sciences, researchers collected blood samples from 32 survivors age 91-101 years and found that all reacted to the 1918 virus, suggesting that they still possessed antibodies to the virus. Samples of the virus utilized were collected by experts from Mount Sinai and the MILITARY Institute of Pathology in 2005 and were taken from the bodies of people killed in the outbreak whose bodies, and the virus, had been preserved in the frozen soil of Alaska permanently. Professor Crowe’s laboratory could make antibodies to the 1918 flu from eight of the samples by isolating the uncommon B cells which are the immune cells that create antibodies, and develop them in tradition.